IM Cannabis annual stock-based compensation
2019
2020
2021
2022
2023
2024
2025
IM Cannabis Stock-Based Compensation Growth & History (IMCC)
IM Cannabis's stock-based compensation was $14,000 for fiscal 2025.
View full IM Cannabis company overviewIM Cannabis annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $14,000 | −$355,000 | −96.21% |
| 2024 | 2024-12-31 | $369,000 | $144,000 | +64.00% |
| 2023 | 2023-12-31 | $225,000 | −$2.4M | −91.47% |
| 2022 | 2022-12-31 | $2.6M | −$2.8M | −51.36% |
| 2021 | 2021-12-31 | $5.4M | $2.0M | +60.32% |
| 2020 | 2020-12-31 | $3.4M | $705,000 | +26.34% |
| 2019 | 2019-12-31 | $2.7M | — | — |
IM Cannabis quarterly stock-based compensation
Q2.21
Q2.22
Q2.23
Q2.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $0 | −$8,000 | — |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $2,000 | — | — |
| Q2 2025 | 2025-06-30 | $4,000 | −$84,000 | −95.45% |
| Q1 2025 | 2025-03-31 | $8,000 | — | — |
| Q2 2024 | 2024-06-30 | $88,000 | −$49,000 | −35.77% |
| Q2 2023 | 2023-06-30 | $137,000 | −$595,000 | −81.28% |
| Q2 2022 | 2022-06-30 | $732,000 | −$641,000 | −46.69% |
| Q2 2021 | 2021-06-30 | $1.4M | — | — |
IM Cannabis stock-based compensation trends
Over the last five fiscal years, IM Cannabis's stock-based compensation decreased from $3.4M to $14,000, a change of −$3.4M. The latest reported quarter, Q1 2026, shows $0.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review IM Cannabis source filings ↗